Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19238802 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.
Condition: Restless Legs Syndrome
Interventions: Drug: XP13512 (GSK1838262);   Other: placebo

Indicates status has not been verified in more than two years